Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
ZyVersa Therapeutics
Sort By
Newest First
1 / 1
1 / 1
Drug Development
ZyVersa Therapeutics Advances Development of Lead Inflammasome Inhibitor Candidate, IC 100
ZyVersa Therapeutics, Inc.
PR-M09-19-NI-022
Sep 10, 2019
